Navigation Links
Karmanos Cancer Institute Announces Interim Leadership
Date:3/5/2009

DETROIT, March 5 /PRNewswire-USNewswire/ -- The Barbara Ann Karmanos Cancer Institute and Karmanos Cancer Center boards of directors today announced that effective immediately Ann G. Schwartz, Ph.D. has been appointed Interim President and Chief Executive Officer, and Paul Broughton has been appointed Interim Chief Operating Officer.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSLOGO )

"Dr. Schwartz is an excellent choice to lead us during this period of transition," said Alan S. Schwartz, Chair, Karmanos Cancer Institute Board of Directors. "As Interim President and Chief Executive Officer, Ann will focus on leading the Institute's scientific direction, while continuing our outstanding world-class research in basic, clinical and population sciences," noted Alan Schwartz.

Having rejoined the Karmanos faculty 10 years ago, Dr. Schwartz, who is unrelated to Alan Schwartz, has extensive experience and knowledge of the Institute.

Previous to this appointment, Dr. Schwartz served as the Associate Center Director for Population Sciences at Karmanos since 2002. Her research focuses on the genetics underlying lung cancer risk. She has an M.S. in Biology from Wayne State University, an M.P.H. in Environmental Health from the University of Michigan, and a Ph.D. in Epidemiology from the University of Michigan School of Public Health.

Dr. Schwartz' first faculty appointment was with the Michigan Cancer Foundation in 1986. She spent 1991-1999 at the University of Pittsburgh and the MCP-Hahnemann School of Medicine. She returned to Karmanos in 1999. Dr. Schwartz has been the recipient of continuous grant support from the National Institutes of Health for more than 20 years.

As Interim Chief Operating Officer, Broughton's main responsibilities include the smooth and efficient operation of the Karmanos Cancer Center to ensure the delivery of high quality care at the hospital and all of the Karmanos clinical operations while continuing their profitability.

Broughton served on both Karmanos boards through December 2007 and was a member of the Institute's Finance and Compensation committees. Prior to his retirement, he was President and Chief Executive Officer of Harper Hospital and Children's Hospital of Michigan.

He is also a Fellow in the American College of Healthcare Executives and a Fellow in the Hospital Financial Management Association.

"Ann will work directly with Paul Broughton, our Interim Chief Operating Officer, to continue our excellence in clinical care for our patients. Both Ann and Paul have extensive knowledge and understanding of our commitment to patient care and cancer research," said Alan Schwartz.

"I am delighted that Ann Schwartz was named interim chief executive officer of the Karmanos Cancer Institute," said Wayne State University President Jay Noren. "As an experienced researcher and administrator, Dr. Schwartz will be a significant asset for the Institute as it continues to fulfill and expand its role as one of the nation's preeminent cancer research and treatment centers."

"The faculty and staff of the Wayne State University School of Medicine are looking forward to working closely with Dr. Schwartz as she assumes leadership of the Karmanos Cancer Institute," said Robert Mentzer, M.D., dean of the Wayne State University School of Medicine. "The medical school and the Institute have a tradition of cooperation in medical research, patient care and teaching that has become a model for medical institutions across the country."

"I have worked with Ann for more than six years. She is an exemplary researcher who is dedicated to finding a cure for this insidious disease. She is a strong leader and will serve the Institute well during this transition," said John C. Ruckdeschel, M.D., the outgoing president and CEO of the Karmanos Cancer Institute.

Karmanos board leadership has worked closely with Wayne State University and its School of Medicine throughout the process of naming an interim leader and will continue to do so as they engage in a nationwide search for the permanent position.

About The Barbara Ann Karmanos Cancer Institute

Located in mid-town Detroit, MI, the Barbara Ann Karmanos Cancer Institute is one of 40 National Cancer Institute-designated comprehensive cancer centers in the United States. Caring for more than 6,000 new patients annually on a budget of $216 million, conducting more than 700 cancer-specific scientific investigation programs and clinical trials, the Karmanos Cancer Institute is among the nation's best cancer centers. Through the commitment of 1,000 staff, including nearly 300 faculty members, and supported by thousands of volunteer and financial donors, the Institute strives to prevent, detect and eradicate all forms of cancer. For more information call 1-800-KARMANOS or go to www.karmanos.org.


'/>"/>
SOURCE Barbara Ann Karmanos Cancer Institute
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Susan G. Komen for the Cure, Karmanos Cancer Institute, Community Leaders, Breast Cancer Survivors and Activists to Gather at Forum and Call for Action on Breast Cancer
2. Susan G. Komen For The Cure, Karmanos Cancer Institute, Local Hospitals Call on Policymakers to Address Injustice and Unfairness in Breast Cancer Incidence and Mortality
3. Karmanos Cancer Center Most Preferred Hospital for Cancer Care According to 2007 Survey
4. Danialle Karmanos Work It Out Launches Dynamic Blog
5. Kroger Pink Tag Campaign Raises $137,500 for Breast Cancer Research and Awareness at Karmanos Cancer Institute
6. Nominations for Outstanding Cancer Survivor Award Being Accepted by Karmanos Cancer Institute Through April 27
7. McCarty Cancer Foundation Awards $50,000 Grant for Myeloma Research Program at Karmanos Cancer Institute
8. Karmanos Researchers Report Enhanced Chemosensitivity of Pancreatic Cancer Cells by Black Seed Component
9. Karmanos Cancer Center Partners With Meadowbrook to Expand Outreach and Access for Cancer Services
10. J.P. McCarthy Fund Grants $250,000 to Karmanos Cancer Institute
11. Karmanos Cancer Center Most Preferred Hospital for Cancer Care in Southeast Michigan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... ... autologous fat (adipose) transfer systems announces the issuance of United States Patent Number ... for its adipose filtration technology. The '398 and '324 patents cover methods ...
(Date:7/24/2017)... ... July 24, 2017 , ... Paul Vitenas, MD, FACS is excited to ... surgeons, invited to attend Allergan’s recent meeting with their Plastics Advisory Board. As one ... world, Allergan is bringing a newly defined structure to the aesthetics market. Dr. ...
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... ... **Presented by FDAnews and MSceppa Consulting **, Aug. 22-23, 2017 – Arlington, VA, ... Friday, July 28. , Increased FDA scrutiny and growing demands to track and ...
(Date:7/24/2017)... , ... July 24, 2017 , ... “Nana Nana Boo ... importance of being kind to others. “Nana Nana Boo Boo” is the creation of ... man. , Published by Christian Faith Publishing, Michael Rush’s new book presents the ...
(Date:7/23/2017)... ... July 23, 2017 , ... ... provider of education and training standards for healthcare treatment providers, offers healthcare ... Certification: the iaedp™ Core Curriculum. , Presented as either online or as ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... founder of Echenberg Institute, is announcing a new safe and effective at-home ... and other painful pelvic pain conditions such as pelvic floor dysfunction, vulvodynia, ... ... ... start-up company, VuVatech LLC, fills a void in the women,s wellness market ...
(Date:7/10/2017)... 10, 2017  The tenth annual BioPharm America™ ... at the Sheraton Boston Hotel, September 26–27. ... to global decision makers and innovative biotech startup companies. ... leaders during two impactful days. BioPharm America is now ... additional networking opportunities with 4,500+ life science industry influencers ...
Breaking Medicine Technology: